Brevan Howard Capital Management
FLGT icon

Brevan Howard Capital Management’s Fulgent Genetics FLGT Stock Holding History

Brevan Howard Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$920K Buy
+44,812
New +$760K 0.01% 1110
2025
Q4 		– Sell
-22,541
Closed -$509K – 1961
2025
Q3 		$509K Buy
+22,541
New +$464K ﹤0.01% 1285
2025
Q2 		– Sell
-44,526
Closed -$752K – 1897
2025
Q1 		$752K Buy
+44,526
New +$758K 0.01% 597

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brevan Howard Capital Management's FLGT Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 44,812 shares worth $920K. The stake represents 0.01% of the portfolio and ranks #1110 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in FLGT as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in FLGT in Q1 2025 and has held it in 3 quarters since. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Brevan Howard Capital Management held 44,812 shares of Fulgent Genetics worth $920K as of Q2 2026.
  • Fulgent Genetics was a new Brevan Howard Capital Management position in Q2 2026.
  • Fulgent Genetics made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1110 holding.
  • Brevan Howard Capital Management first reported a position in Fulgent Genetics in Q1 2025 and has held it in 3 quarters since.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.